Search research articles
Contact Us
Filters
Showing results (51-60 of 159) with videos related to
Page
of 16
Sort By:
Indian Journal of Medical Microbiology
|
February 14, 2026
Plazomicin Activity against Carbapenem-Resistant Escherichia coli: A Brief Report
Priti Kambli, Shaoli Basu, Susan Rodrigues, et al.
Journal of Clinical Medicine
|
June 27, 2024
No Evidence of Chronic Infection in a Metagenomic Sequencing Study of the Keratoconus Corneal Epithelium
Pritpal Kaur, Loren Moon, Divya Srikumaran, et al.
The Journal of Antimicrobial Chemotherapy
|
October 23, 2024
Differential frequency of persister cells in clinically derived isolates of Pseudomonas aeruginosa after exposure to cefiderocol and ceftolozane/tazobactam
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 21, 2019
Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Organisms?
Sima L Sharara, Joe Amoah, Zoi D Pana, et al.
Diagnostic Microbiology and Infectious Disease
|
September 6, 2011
Fluoroquinolone resistance in Escherichia coli isolated from patients attending Canadian hospitals is associated with the ST131 clone
Patricia J Simner, Daryl J Hoban, Philippe R S Lagacé-Wiens, et al.
Journal of Clinical Microbiology
|
September 8, 2017
Multisite Evaluation of the BD Max Extended Enteric Bacterial Panel for Detection of Yersinia enterocolitica, Enterotoxigenic Escherichia coli, Vibrio, and Plesiomonas shigelloides from Stool Specimens
Patricia J Simner, Margret Oethinger, Kathleen A Stellrecht, et al.
The Journal of Antimicrobial Chemotherapy
|
April 2, 2024
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.
Infectious Diseases (London, England)
|
March 5, 2025
Comparison of the <i>in vivo</i> efficacy and resistance development potential between cefiderocol and ceftolozane/tazobactam human simulated exposures against <i>Pseudomonas aeruginosa in</i> 72-hour murine thigh infection model
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.
Antimicrobial Agents and Chemotherapy
|
May 30, 2019
The Likelihood of Developing a Carbapenem-Resistant <i>Enterobacteriaceae</i> Infection during a Hospital Stay
Pranita D Tamma, Abida Kazmi, Yehudit Bergman, et al.
Journal of Clinical Microbiology
|
May 14, 2025
Development of disk diffusion susceptibility test methods for <i>Aerococcus</i> spp. and updates to Clinical and Laboratory Standards Institute MIC breakpoints
Richard Maynard, Carmila Manuel, Synthia Simpkins, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 159) with videos related to
Sort By:
Page
of 16
Indian Journal of Medical Microbiology
|
February 14, 2026
Plazomicin Activity against Carbapenem-Resistant Escherichia coli: A Brief Report
Priti Kambli, Shaoli Basu, Susan Rodrigues, et al.
Journal of Clinical Medicine
|
June 27, 2024
No Evidence of Chronic Infection in a Metagenomic Sequencing Study of the Keratoconus Corneal Epithelium
Pritpal Kaur, Loren Moon, Divya Srikumaran, et al.
The Journal of Antimicrobial Chemotherapy
|
October 23, 2024
Differential frequency of persister cells in clinically derived isolates of Pseudomonas aeruginosa after exposure to cefiderocol and ceftolozane/tazobactam
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 21, 2019
Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Organisms?
Sima L Sharara, Joe Amoah, Zoi D Pana, et al.
Diagnostic Microbiology and Infectious Disease
|
September 6, 2011
Fluoroquinolone resistance in Escherichia coli isolated from patients attending Canadian hospitals is associated with the ST131 clone
Patricia J Simner, Daryl J Hoban, Philippe R S Lagacé-Wiens, et al.
Journal of Clinical Microbiology
|
September 8, 2017
Multisite Evaluation of the BD Max Extended Enteric Bacterial Panel for Detection of Yersinia enterocolitica, Enterotoxigenic Escherichia coli, Vibrio, and Plesiomonas shigelloides from Stool Specimens
Patricia J Simner, Margret Oethinger, Kathleen A Stellrecht, et al.
The Journal of Antimicrobial Chemotherapy
|
April 2, 2024
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.
Infectious Diseases (London, England)
|
March 5, 2025
Comparison of the <i>in vivo</i> efficacy and resistance development potential between cefiderocol and ceftolozane/tazobactam human simulated exposures against <i>Pseudomonas aeruginosa in</i> 72-hour murine thigh infection model
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.
Antimicrobial Agents and Chemotherapy
|
May 30, 2019
The Likelihood of Developing a Carbapenem-Resistant <i>Enterobacteriaceae</i> Infection during a Hospital Stay
Pranita D Tamma, Abida Kazmi, Yehudit Bergman, et al.
Journal of Clinical Microbiology
|
May 14, 2025
Development of disk diffusion susceptibility test methods for <i>Aerococcus</i> spp. and updates to Clinical and Laboratory Standards Institute MIC breakpoints
Richard Maynard, Carmila Manuel, Synthia Simpkins, et al.
Page
of 16